Thomas Gayner - Markel Asset Management
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 2,150,000 | 2.42 | $103.45 | ||
| 2023 Q3 | 2,150,000 | 2.36 | $90.94 | ||
| 2023 Q2 | 2,150,000 | 2.07 | $80.92 | ||
| 2023 Q1 | 2,150,000 | 2.18 | $79.57 | ||
| 2022 Q4 | 2,150,000 | 1.95 | $67.67 | ||
| 2022 Q3 | 2,150,000 | 1.58 | $49.82 | ||
| 2022 Q2 | 2,150,000 | 1.71 | $55.71 | ||
| 2022 Q1 | 2,150,000 | 1.42 | $55.53 | ||
| 2021 Q4 | 2,150,000 | 1.38 | $56.00 | ||
| 2021 Q3 | 2,150,000 | 1.30 | $48.01 | ||
| 2021 Q2 | 2,150,000 | 1.14 | $41.89 | ||
| 2021 Q1 | 2,150,000 | 1.00 | $33.71 | ||
| 2020 Q4 | 2,150,000 | 1.12 | $34.93 | ||
| 2020 Q3 | 2,150,000 | 1.27 | $34.71 | ||
| 2020 Q2 | 2,150,000 | 1.31 | $32.74 | ||
| 2020 Q1 | 2,150,000 | 1.22 | $30.10 | ||
| 2019 Q4 | 2,150,000 | 0.86 | $28.94 | ||
| 2019 Q3 | 2,150,000 | 0.84 | $25.85 | ||
| 2019 Q2 | 2,150,000 | 0.84 | $25.52 | ||
| 2019 Q1 | 2,150,000 | 0.94 | $26.15 | ||
| 2018 Q4 | 2,150,000 | 0.95 | $23.03 | ||
| 2018 Q3 | 2,150,000 | 0.85 | $23.57 | ||
| 2018 Q2 | 2,150,000 | 0.91 | $23.06 | ||
| 2018 Q1 | 2,150,000 | 1.01 | $24.63 | ||
| 2017 Q4 | 2,150,000 | 1.09 | $26.83 | ||
| 2017 Q3 | 2,150,000 | 1.03 | $24.07 | ||
| 2017 Q2 | 2,150,000 | 0.98 | $21.45 | ||
| 2017 Q1 | 2,150,000 | 0.83 | $17.14 | ||
| 2016 Q4 | 2,150,000 | 0.93 | $17.93 | ||
| 2016 Q3 | 2,150,000 | 1.15 | $20.79 | ||
| 2016 Q2 | 2,150,000 | 1.52 | $26.89 | ||
| 2016 Q1 | 2,150,000 | 1.56 | $27.09 | ||
| 2015 Q4 | 2,150,000 | 1.69 | $29.04 | ||
| 2015 Q3 | 2,150,000 | 1.54 | $27.12 | ||
| 2015 Q2 | 2,150,000 | 1.47 | $27.38 | ||
| 2015 Q1 | 2,150,000 | 1.45 | $26.69 | ||
| 2014 Q4 | 2,150,000 | 1.20 | $21.16 | ||
| 2014 Q3 | 2,150,000 | 1.44 | $23.81 | ||
| 2014 Q2 | 2,150,000 | 1.42 | $23.09 | ||
| 2014 Q1 | 2,150,000 | 1.51 | Reduce 2.80% | 0.04 | $22.83 |
| 2013 Q4 | 2,212,000 | 1.29 | Reduce 0.23% | 0.00 | $18.48 |
| 2013 Q3 | 2,217,000 | 1.29 | Reduce 1.51% | 0.02 | $16.92 |
| 2013 Q2 | 2,251,000 | 1.25 | Reduce 0.57% | 0.01 | $15.50 |
| 2013 Q1 | 2,264,000 | 1.36 | Reduce 0.40% | 0.01 | $16.15 |
| 2012 Q4 | 2,273,000 | 1.55 | Reduce 0.35% | 0.01 | $16.32 |
| 2012 Q3 | 2,281,000 | 1.54 | Reduce 0.35% | 0.01 | $15.78 |
| 2012 Q2 | 2,289,000 | 1.52 | Add 0.84% | 0.01 | $14.53 |
| 2012 Q1 | 2,270,000 | 1.45 | Reduce 0.96% | 0.01 | $13.87 |
| 2011 Q4 | 2,292,000 | 1.39 | Reduce 0.11% | 0.00 | $11.53 |
| 2011 Q3 | 2,294,500 | 1.40 | $9.95 | ||
| 2011 Q2 | 2,294,500 | 1.53 | Reduce 0.09% | 0.00 | $12.53 |
| 2011 Q1 | 2,296,500 | 1.56 | Reduce 0.43% | 0.01 | $12.52 |
| 2010 Q4 | 2,306,500 | 1.45 | Reduce 0.09% | 0.00 | $11.26 |
| 2010 Q3 | 2,308,500 | 1.37 | Reduce 0.28% | 0.00 | $9.84 |
| 2010 Q2 | 2,315,000 | 1.28 | $8.10 | ||
| 2010 Q1 | 2,315,000 | 1.11 | Add 39.04% | 0.31 | $7.71 |
| 2009 Q4 | 1,665,000 | 0.75 | Buy | 0.75 | $6.38 |